Requisition of General Meeting

The Board of Oxford Cannabinoid Technologies Holdings plc (the "Board") announces that it has today received a letter (the "Letter") from Gavin Sathianathan in his capacity as Chairman, CEO and Director of GHS Capital Limited, which is the holder of 78,146,151 ordinary shares, representing 8.14 per cent of the issued ordinary share capital in the Company. Mr Sathianathan resigned from his role as non-executive director of the Company on 24 November 2021.

The Letter requests the Company to convene a general meeting of the Company's shareholders pursuant to section 303 of the Companies Act 2006 (the "Act") and consider and, if thought fit, propose resolutions to remove Neil Mahapatra, Julie Pomeroy, John Lucas, Cheryl Dhillon, Bishrut Mukherjee and Richard Hathaway as directors of the Company, and to appoint James Brodie, Richard Bedford and Richard Grethe, as directors of the Company.

The Board intends to comply with its obligations in accordance with section 304 of the Act which requires it to call a general meeting within 21 days of receipt of a valid requisition and to hold such general meeting on a date not more than 28 days after the date of the notice convening such general meeting.

Shareholders are advised to take no action at this time. Further announcements will be made in due course.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

The Directors of the Company accept responsibility for the content of this announcement.